Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Current Topics in Virology   Volumes    Volume 1 
Abstract
Targeting HIV-1 gp120 to the high affinity FC receptor (FCγRI, CD64) on myeloid antigen presenting cells: implications for enhancing vaccine responses
Alexandra L. Howell, Tara N. Thacker, Fang Li, Steve Fiering, Robert F. Graziano, Joel Goldstein, Michael W. Fanger
Pages: 61 - 70
Number of pages: 10
Current Topics in Virology
Volume 1 

Copyright © 1999 Research Trends. All rights reserved

ABSTRACT

We prepared a fusion protein containing a humanized monoclonal antibody (mAb), mAb H22, with specificity for the human high affinity Fc receptor for IgG (FcγRI, CD64), fused to HIV-1 gp120. This fusion protein construct was produced by joining the cDNA for the full length H22 heavy chain gene in frame to the cDNA for gp120. This construct, which also expressed a selectable marker, was stably transfected into a murine myeloma cell line that expressed the previously transfected H22 kappa light chain. The resulting fusion protein, (H22 x gp120), was secreted from the myeloma cell line and was purified by affinity chromatography. Flow cytometric analysis revealed that H22 x gp120 bound with high affinity via the Fab portion of H22 to CD64 expressed on monocytes and macrophages from both humans and human CD64- expressing transgenic mice. Western blot analysis revealed that the 390 kDa fusion protein reacted with both anti-human IgG and anti-gp120 mAbs. Incubation of a monocyte cell line with this fusion protein at 37°C resulted in internalization of the complex as determined by flow cytometric analysis. Immunization of human CD64 transgenic mice with the purified H22 x gp120 fusion protein induced higher titers of anti-gp120 serum antibodies compared to immunization of non-transgenic littermates. Targeting gp120 to CD64-expressing antigen presenting cells (APC) in vivo may augment immune responses and enhance protective immunity.

Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms